BriaCell Therapeutics Corp. (BCTX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. William V. Williams FCPA, M.D.
|
CEO, President & Director | 872.35k | -- | 1955 |
|
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.
|
CFO & Corporate Secretary | 564.59k | -- | 1973 |
|
Dr. Giuseppe Del Priore M.D., M.P.H.
|
Chief Medical Officer | 625.4k | -- | 1962 |
BriaCell Therapeutics Corp.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 31
Description
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. The company is headquartered in West Vancouver, Canada.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
